Exploration of fully-automated body composition analysis using routine CT-staging of lung cancer patients for survival prognosis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: AI‐driven automated body composition analysis (BCA) may provide quantitative prognostic biomarkers derived from routine staging CTs. This two‐centre study evaluates the prognostic value of these volumetric markers for overall survival in lung cancer patients. Methods: Lung cancer cohorts from Hospital A ( n = 3345, median age 65, 86% NSCLC, 40% M1, 40% female) and B ( n = 1364, median age 66, 87% NSCLC, 37% M1, 38% female) underwent automated BCA of abdominal CTs ±60 days of primary diagnosis. A deep learning network segmented muscle, bone and adipose tissues (visceral = VAT, subcutaneous = SAT, intra‐/intermuscular = IMAT and total = TAT) to derive three markers: Sarcopenia Index (SI = Muscle/Bone), Myosteatotic Fat Index (MFI = IMAT/TAT) and Abdominal Fat Index (AFI = VAT/SAT). Kaplan–Meier survival analysis, Cox proportional hazards modelling and machine learning‐based survival prediction were performed. A survival model including clinical data (BMI, ECOG, L3‐SMI, ‐SATI, ‐VATI and ‐IMATI) was fitted on Hospital A data and validated on Hospital B data. Results: In nonmetastatic NSCLC, high SI predicted longer survival across centres for males (Hospital A: 24.6 vs. 46.0 months; Hospital B: 13.3 vs. 28.9 months; both p < 0.001) and females (Hospital A: 37.9 vs. 53.6 months, p = 0.008; Hospital B: 23.0 vs. 28.6 months, p = 0.018). High MFI indicated reduced survival in males at both hospitals (Hospital A: 43.7 vs. 28.2 months; Hospital B: 28.8 vs. 14.3 months; both p ≤ 0.001) but showed center‐dependent effects in females (significant only in Hospital A, p < 0.01). In metastatic disease, SI remained prognostic for males at both centres ( p < 0.05), while MFI was significant only in Hospital A ( p ≤ 0.001) and AFI only in Hospital B ( p = 0.042). Multivariate Cox regression confirmed that higher SI was protective (A: HR 0.53, B: 0.59, p ≤ 0.001), while MFI was associated with shorter survival (A: HR 1.31, B: 1.12, p < 0.01). The multivariate survival model trained on Hospital A's data demonstrated prognostic differentiation of groups in internal ( n = 209, p ≤ 0.001) and external (Hospital B, n = 361, p = 0.044) validation, with SI feature importance (0.037) ranking below ECOG (0.082) and M‐status (0.078), outperforming all other features including conventional L3‐single‐slice measurements. Conclusion: CT‐based volumetric BCA provides prognostic biomarkers in lung cancer with varying significance by sex, disease stage and centre. SI was the strongest prognostic marker, outperforming conventional L3‐based measurements, while fat‐related markers showed varying associations. Our multivariate model suggests that BCA markers, particularly SI, may enhance risk stratification in lung cancer, pending centre‐specific and sex‐specific validation. Integration of these markers into clinical workflows could enable personalized care and targeted interventions for high‐risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“skeletal muscle depletion, adipose infiltration, and altered body composition have been associated with survival, treatment tolerance, and adverse outcomes in patients with cancer, including lung cancer (11–14).”
In the citing paper
“Single-slice computed tomography (CT)-based body-composition analysis has provided important prognostic information, but it may not fully represent the three-dimensional (3D) distribution of thoracic muscle and intermuscular fat in patients undergoing thoracic RT (13, 15, 16).”
In the citing paper
“Previous studies in patients with lung cancer have linked CT-derived measures of skeletal muscle, adiposity, and body composition with survival and other clinical outcomes (9–14).”
In the citing paper
“Automated CT segmentation has increasingly been used for body-composition analysis and other quantitative imaging tasks, with growing interest in clinical implementation (13, 16–19, 33, 34).”
In the citing paper
“CT-based studies in lung cancer have evaluated muscle quantity and muscle attenuation as distinct components of body composition, and both have been associated with clinical outcomes (9, 10, 13, 14).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia
Scharping, N. E., Menk, A. V., Whetstone, R. D., Zeng, X., & Delgoffe, G. M. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0103 · Cited by 520 · cited 1×
“Metformin, studied for its anticancer and immunomodulatory effects, shows variable potency in preclinical and clinical studies [35] [S7].”
Implications of low muscle mass across the continuum of care: a narrative review
Prado, C. M., Purcell, S. A., Alish, C., Pereira, S. L., Deutz, N. E., Heyland, D. K., Goodpaster, B. H., Tappenden, K. A., & Heymsfield, S. B. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1511918 · Cited by 286 · cited 1×
“Lastly, BCA could enable risk-stratified trial design and the monitoring of treatment-related changes in body composition over time [37, 38].”
Fat mass changes during menopause: a metaanalysis
Ambikairajah, A., Walsh, E., Tabatabaei-Jafari, H., & Cherbuin, N. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.04.023 · Cited by 255 · cited 1×
“In contrast, VAT, which is more prevalent in men and postmenopausal women, is metabolically active and associated with insulin resistance, cardiovascular disease and systemic inflammation [22, 23].”
Research works printed but not linked: 34
- 10.3322/caac.21590 · DOI · Paper page
- 10.1038/nature25183 · DOI · Paper page
- 10.1038/s41591-021-01450-2 · DOI · Paper page
- 10.2174/18715206113139990322 · DOI · Paper page
- Jamadi RH Stretch C Armstrong V et al. “Sex‐Specific Body Composition Features Impacting Survival Outcomes in Surgically Managed Clear Cell Renal Cell Carcinoma”. Published Online November 4 2024. Accessed April 25 2025 https://www.researchsquare.com/article/rs‐5313658/v1. · doi:10.21203/rs.3.rs-5313658/v1
- 10.1200/JCO.2012.45.2722 · DOI · Paper page
- 10.3390/cancers11091304 · DOI
- 10.1016/j.jtho.2018.04.035 · DOI · Paper page
- 10.1016/j.semcdb.2015.09.001 · DOI · Paper page
- 10.1097/RTI.0000000000000428 · DOI
- 10.1200/CCI.20.00045 · DOI · Paper page
- 10.1001/jamanetworkopen.2021.15274 · DOI
- 10.3390/cancers14061440 · DOI
- 10.1016/j.jtho.2021.04.020 · DOI
- 10.1038/s41571-023-00734-5 · DOI · Paper page
- 10.3389/fonc.2022.890745 · DOI
- 10.1002/jcsm.12528 · DOI · Paper page
- 10.3390/surgeries4020027 · DOI
- 10.1016/j.critrevonc.2019.102839 · DOI · Paper page
- 10.1016/j.mad.2021.111563 · DOI
- Maltais M. L., 2009, Changes in Muscle Mass and Strength After Menopause, Journal of Musculoskeletal & Neuronal Interactions, 9, 186
- J.Romano J. D.Kromrey J.Coraggio J.Skowronek L.Devine“Exploring Methods for Evaluating Group Differences on the NSSE and Other Surveys: Are the T‐Test and Cohen's D Indices the Most Appropriate Choices?” In: Citeseer;2006:1–51.
- 10.2147/CMAR.S195869 · DOI · Paper page
- 10.1038/bjc.2017.149 · DOI · Paper page
- 10.1093/oxfordjournals.aje.a009520 · DOI · Paper page
- 10.1016/j.mri.2023.01.005 · DOI
- 10.1016/j.afos.2021.03.002 · DOI
- 10.1152/japplphysiol.00196.2023 · DOI
- 10.1161/JAHA.120.019968 · DOI · Paper page
- 10.1002/jcsm.13520 · DOI
- 10.1186/s12966-021-01142-7 · DOI · Paper page
- 10.1007/s00520-018-4297-8 · DOI
- 10.1148/radiol.222937 · DOI
- 10.1002/jcsm.13478 · DOI
Cited by
Sung, S., Choi, H. J., Jeong, S., Cho, W., Kim, Y. J., Cha, H., Min, C. H., & Kim, M. S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1946212
Metadata
- Authors
- Künnemann, M., Römer, C., Helfen, A., Bleckmann, A., Kemper, M., Heindel, W., Brix, T. J., Forsting, M., Haubold, J., Opitz, M., Schuler, M., Nensa, F., Borys, K., & Hosch, R.
- Affiliations
- Clinic for Radiology University of Münster and University Hospital Münster Münster Germany
- West German Cancer Center (WTZ) University Hospital Münster Münster Germany
- Institute of Medical Informatics University of Münster Münster Germany
- Institute of Diagnostic and Interventional Radiology and Neuroradiology University Hospital Essen Essen Germany
- West German Cancer Center (WTZ), Department of Medical Oncology University Hospital Essen Essen Germany
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2025-08
- Volume
- 16
- Issue
- 4
- ISSN
- 2190-5991
- 2190-6009
- Cited by
- 14
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.